1.35 (0.15%) Pursuant to Regulation 39(3) of the Listing Regulations, Zydus Lifesciences has informed that the company has received information of loss of share certificate and request for issue of duplicate share certificate as details enclosed.
The above information is a part of company’s filings submitted to BSE.